Immunocal®: The Glutathione-Boosting Discovery Endorsed by N

Dr. Luc Montagnier received the Nobel Prize in Medicine in 2008 along with his colleague Francoise Barre-Sinoussi, for discovering the HIV VIRUS. 

In 1994, Montagnier drew attention to the promising effects of Immunotec’s cornerstone product, Immunocal®, a proven precursor of the major cellular antioxidant glutathione, in his opening address at the 10th International AIDS Conference in Yokohama, Japan. 

The anti-HIV and anti-apoptotic activity of Immunocal and its relation with GSH synthesis were further discussed in a presentation at the same conference. 

Three years later, Montagnier, Olivier, and Catherine Pasquier edited Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper co-authored by Immunotec founding scientist Dr. Gustavo Bounous. Entitled Nutraceutical Modulation of Glutathione with a Humanized Native Milk Serum Protein Isolate, Immunocal: Application in AIDS and Cancer, the paper explored the extremely rare glutathione-promoting components of proteins in Immunocal and noted the implication of cellular glutathione depletion in a number of degenerative conditions and disease states including Parkinson’s, Alzheimer’s, arteriosclerosis, cataracts, cystic fibrosis, malnutrition, aging, AIDS, and cancer.